Takara Bio Corrects Share Count Figure in Extraordinary Meeting Notice

Takara Bio Inc. ( (JP:4974) ) has issued an announcement.

Takara Bio Inc. has issued a correction to its previously distributed notice convening an extraordinary general meeting of shareholders on proposed share consolidation and related amendments to its Articles of Incorporation. The company clarified that, if the share consolidation plan is approved and implemented, the total number of issued shares will be six, not 24 as originally stated, while maintaining the plan to abolish the provision on share units and delete the article specifying 100 shares per unit.

The correction is limited to the numerical figure for the post-consolidation share count in the explanatory section on the reasons for amending the Articles of Incorporation. While the operational substance of the proposed consolidation and the abolition of share units remains unchanged, the updated figure provides shareholders and investors with accurate information on the company’s capital structure following the planned share consolidation.

The most recent analyst rating on (JP:4974) stock is a Hold with a Yen940.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.

More about Takara Bio Inc.

Takara Bio Inc. is a Japan-based biotechnology company listed on the Tokyo Stock Exchange Prime section under securities code 4974. The company focuses on genetic engineering and life science research tools, as well as related biopharmaceutical and regenerative medicine businesses serving academic, clinical, and industrial markets.

Average Trading Volume: 777,964

Technical Sentiment Signal: Sell

Current Market Cap: Yen137.4B

See more insights into 4974 stock on TipRanks’ Stock Analysis page.